Search clinical trials for: FEV1

Total 115 results

Peking University First Hospital
The Second Hospital of Hebei Medical University; First Affiliated Hospital... and other collaborators

Completed

Predictive Value of Inflammatory Biomarkers and FEV1 for COPD (PIFCOPD)

COPD | FEV1

China
Lifespan

Completed

Evaluating the Effectiveness of Incentive Spirometry

Pneumonia | Dyspnea | Atelectasis | Respiratory Rate | Oxygen Saturation | Oxygen Requirements | FEV1 | FVC | Re-intubation | Hospital Length of Stay | Nursing Workload | Incentive Spirometry

United States
University of Zurich

Completed

Pulmonary Involvement in Patients With Fabry Disease

Fabry Disease

Switzerland
Hospital Clinic of Barcelona

Completed

Dyspnea in COPD: Relationship With Exacerbations Frequency (DPE)

Dyspnea

Spain
Hospital Clinic of Barcelona

Unknown

Pulmonary Gas Exchange Response to Indacaterol in COPD

Chronic Obstructive Pulmonary Disease

Spain
The Hospital for Sick Children

Unknown

Rapid Versus Prolonged Inpatient Up-Titration of Captopril

Heart Disease

Canada
Imperial College London
Royal Brompton & Harefield NHS Foundation Trust

Completed

Exacerbations in Severe Asthma Patients: Mechanisms and Biomarkers

Asthma

United Kingdom
University of Patras

Recruiting

Lung Function Variability in Children and Adolescents (LUV)

Asthma in Children | Lung Function Decreased

Greece
AstraZeneca

Completed

Multi-centre Study to Assess the Efficacy and Safety of AZD5423 in COPD Patients on a Background Therapy of Formoterol

Chronic Obstructive Pulmonary Disease (COPD)

Bulgaria, France, Italy, Poland, Russian Federation, Ukraine, Hungary, Slovakia
Cliniques universitaires Saint-Luc- Université...

Completed

FEV1/FEV6 and FEV6 as an Alternative for FEV1/FVC and FVC in Bolivian Subjects

Copd

Bolivia
Centre Hospitalier Universitaire de Besancon

Terminated

Characterization of Professional COPD Related to Exposure to Organic Dust - Mean Follow up at 6 Years (BALISTIC 2)

COPD | Exposure Occupational

France
CHC MontLégia

Active, not recruiting

Daily Monitoring of Respiratory Symptoms and Spirometry During ETI Treatment in Persons With Cystic Fibrosis.

Cystic Fibrosis

Belgium
University of Milan

Unknown

Effect of add-on Doxofylline on Lung Function in Stable COPD (EDAI)

Chronic Obstructive Pulmonary Disease

Italy
GlaxoSmithKline

Completed

Patient Characteristics and Treatment Modalities in COPD Patients in China

Pulmonary Disease, Chronic Obstructive

China
GlaxoSmithKline

Completed

Efficacy and Safety Study of Fluticasone Furoate (FF)/GW642444 Inhalation Powder and the Individual Components in Subjects With Chronic Obstructive Pulmonary Disease (COPD)

Pulmonary Disease, Chronic Obstructive

United States, Germany, Japan, Romania, Russian Federation, Ukraine, Argentina, Poland, Czechia
GlaxoSmithKline

Completed

A Comparative Study To Determine If Motivating Asthma Education (Compliance Enhancement) Has An Effect On Asthma Control

Asthma

Denmark, Switzerland
GlaxoSmithKline

Completed

A Study to Evaluate the Effect of Umeclidinium (UMEC) as Combination Therapy in Subjects With Chronic Obstructive Pulmonary Disease (COPD)

Pulmonary Disease, Chronic Obstructive

Germany, Netherlands, Greece, Czechia
Ache Laboratorios Farmaceuticos S.A.

Withdrawn

Efficacy and Safety Study of Formoterol/Fluticasone and Salmeterol/Fluticasone in Patients With Moderate-to-severe COPD

Chronic Obstructive Pulmonary Disease | COPD
GlaxoSmithKline

Completed

A Study to Evaluate the Effect of Repeat Doses of GW870086X in Mild to Moderate Asthmatics

Asthma

Germany
Pharmaxis

Completed

Crossover Trial Determining the Efficacy of Dry Powder Mannitol to Improve Lung Function in Subjects Aged 6-17 Years

Cystic Fibrosis

United Kingdom
Johnson & Johnson Pharmaceutical Research & Development...

Terminated

Effectiveness and Safety Study for JNJ-18054478 in Asthma Patients.

Asthma

United States, Costa Rica, India
Hannover Medical School
Mallinckrodt

Terminated

Extracorporeal Photopheresis in Patients With Bronchiolitis Obliterans Syndrome (BOS) After Lung Transplantation

Bronchiolitis Obliterans

Germany
Assistance Publique - Hôpitaux de Paris

Unknown

Management of Patients With Alpha-1 Antitrypsin Deficiency Associated Emphysema

Emphysema | Alpha 1-Antitrypsin Deficiency

France
University of Glasgow
NHS Greater Glasgow and Clyde; NHS Greater Clyde and Glasgow; Asthma UK

Completed

Trial to Evaluate the Effect of Statins on Asthma Control of Patients With Chronic Asthma

Asthma

United Kingdom
The Hong Kong Polytechnic University

Completed

Effects of a 4-week Acu-Transcutaneous Electrical Nerve Stimulation (Acu-TENS) Program on Subjects With Stable Chronic Obstructive Pulmonary Disease (COPD)

Chronic Obstructive Pulmonary Disease (COPD)

China
Boehringer Ingelheim

Completed

Spiriva® Assessment of FEV1 (SAFE)

Pulmonary Disease, Chronic Obstructive

Canada
GlaxoSmithKline

Terminated

ADVAIR DISKUS® (Fluticasone Propionate/Salmeterol) Inhaler Versus SEREVENT DISKUS® (Salmeterol) Inhlaer On Inflammatory Cells And Markers In Chronic Obstructive Pulmonary Disease. ADVAIR DISKUS® and SEREVENT DISKUS® Inhalers Are Trademarks of the GSK Group of Companies.

Pulmonary Disease, Chronic Obstructive

United States
Areteia Therapeutics

Recruiting

A Study to Assess the Effect of Dexpramipexole in Adolescents and Adults With Eosinophilic Asthma (EXHALE-4)

Asthma Attack | Eosinophilic Asthma | Asthma; Eosinophilic

United States, United Kingdom, Romania, Poland
National Cancer Institute (NCI)

Recruiting

Alvelestat (MPH966), an Oral Neutrophil Elastase Inhibitor, in Bronchiolitis Obliterans Syndrome After Allogeneic Hematopoietic Stem Cell Transplantation

Bronchiolitis Obliterans Syndrome | Chronic Graft vs Host Disease | Chronic Graft-Versus-Host Disease

United States
University of Minnesota

Completed

Pulmonary Substudy: A Substudy of Strategic Timing of AntiRetroviral Treatment (START)

Chronic Obstructive Pulmonary Disease | HIV

United States
Pulmonary Research Institute of Southeast Michigan
GlaxoSmithKline

Completed

Peak Inspiratory Flow and Dry Powder Inhaler Performance in COPD

COPD

United States
Verona Pharma plc

Completed

Bronchodilator Effect of RPL554 Administered in Addition to Tiotropium/Olodaterol in Patients With COPD

COPD

United States, United Kingdom
Janssen Research & Development, LLC

Completed

An Effectiveness and Safety Study of Inhaled JNJ 49095397 (RV568) in Patients With Moderate to Severe Chronic Obstructive Pulmonary Disease

Chronic Obstructive Pulmonary Disease

United Kingdom, United States, Belgium, Germany, Romania, Canada, Netherlands, Russian Federation, Poland, Hungary, Czechia
Mukoviszidose Institut gGmbH
Hannover Medical School; Goethe University; Federal Ministry of Health, Germany; Wuerzburg University Hospital and other collaborators

Completed

Effects of a Comprehensive Patient-centered Health Service in Cystic Fibrosis (VEMSE-CF) (VEMSE-CF)

Cystic Fibrosis

Germany
AstraZeneca

Completed

A Multiple Dosing (14 Days) Study to Assess Efficacy and Safety of Three Dose Levels of AZD7594, Given Once Daily by Inhalation, in Patients With Mild to Moderate Asthma

Asthma | Efficacy | Safety

Germany, Bulgaria
GlaxoSmithKline

Completed

A Study to Evaluate the Efficacy, Safety, Tolerability, Pharmacokinetic (PK), and Pharmacodynamic (PD) Profiles of 3 Doses of Fluticasone Furoate (FF)/GW642444 Inhalation Powder at the End of a 28-day Treatment Period in Subjects With Chronic Obstructive Pulmonary Disease (COPD) Compared to Placebo

Pulmonary Disease, Chronic Obstructive

United States
GlaxoSmithKline

Completed

A Study to Evaluate the Efficacy and Safety of Fluticasone Furoate (FF)/GW642444 Inhalation Powder in Subjects With Chronic Obstructive Pulmonary Disease (COPD)

Pulmonary Disease, Chronic Obstructive

United States, Argentina, Australia, Germany, Estonia, Chile, Netherlands, Peru, South Africa, Sweden, Mexico, United Kingdom, Italy, Philippines, Canada
AstraZeneca

Completed

A Chronic Obstructive Pulmonary Disease (COPD) Trial Investigating Roflumilast on Safety and Effectiveness in China, Hong Kong and Singapore: (ACROSS)

COPD

China, Hong Kong, Singapore
GlaxoSmithKline

Completed

Efficacy and Safety Study in Subjects With Asthma

Asthma

United States
GlaxoSmithKline

Completed

A Study in Asthmatic Patients to Determine if There is Any Difference in Dosing With Fluticasone Furoate/Vilanterol Inhalation Powder in the Morning or Evening on Lung Function

Asthma

New Zealand
AstraZeneca

Completed

Effect on Structural Changes in Airways, Measured by MSCT, of Twice Daily 60mg AZD9668 for 12 Weeks in Chronic Obstructive Pulmonary Disease (COPD) Patients

Chronic Obstructive Pulmonary Disease (COPD)

Romania, Ukraine, Denmark, Netherlands, Canada
AstraZeneca

Completed

Efficacy and Safety of Twice Daily 60mg AZD9668 in COPD for 12 Weeks in Patients on Background Budesonide/Formoterol

Chronic Obstructive Pulmonary Disease (COPD)

Bulgaria, Czech Republic, Poland, Hungary, Romania, Slovakia
AstraZeneca

Completed

A Descriptive Study to Explore Certain Characteristics of Patients at Risk for Chronic Obstructive Pulmonary Disease (COPD) in a Primary Care Setting

Chronic Obstructive Pulmonary Disease

Sweden
Pharmaxis

Completed

Long Term Administration of Inhaled Dry Powder Mannitol In Cystic Fibrosis - A Safety and Efficacy Study

Cystic Fibrosis

Ireland, United Kingdom, Australia
Washington University School of Medicine
American Academy of Pediatrics; Ambulatory Pediatric Association

Terminated

Montelukast Added to Standard Therapy for Acute Asthma in Children Age 6-14 Years

Asthma

United States
The Hong Kong Polytechnic University

Completed

Acute Effects of Acu-Transcutaneous Electrical Nerve Stimulation (Acu-TENS) on Forced Expiratory Flow Volume in One Second (FEV1) and Blood β-Endorphin Level in Subjects With Chronic Obstructive Pulmonary Disease (COPD)

Chronic Obstructive Pulmonary Disease (COPD)

China
The Hong Kong Polytechnic University

Completed

Effect of Acu-Transcutaneous Electrical Nerve Stimulation (TENS) on Post-Exercise Expiratory Flow Rate in Subjects With Asthma

Asthma

Hong Kong
Augusta University

Active, not recruiting

Mechanisms for Vascular Dysfunction and Exercise Tolerance in CF (CF-AOX)

Cystic Fibrosis

United States
Mylan Pharma UK Ltd.

Completed

MGR001 / Advair Diskus Local Equivalence Study in Asthma

Asthma

United States
GlaxoSmithKline

Completed

Effect of the GSK2245035 on the Allergen-induced Asthmatic Response

Asthma

United Kingdom, Germany

3

Subscribe